Cross-seeding of wild-type and hereditary variant-type amyloid β-proteins in the presence of gangliosides

Journal of Neurochemistry

Volumn 95, Issue 4, 2005, Pages 1167-1176

  Yamamoto, Naoki ^a,b   Matsuzaki, Katsumi ^c   Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Cerebral amyloid angiopathy; Ganglioside; Seed

Indexed keywords

AMYLOID BETA PROTEIN; GANGLIOSIDE; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DETERMINATION; WESTERN BLOTTING; WILD TYPE;

AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; CHOLERA TOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GANGLIOSIDOSES; HORSERADISH PEROXIDASE; HUMANS; IMMUNOBLOTTING; LIPOSOMES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, IMMUNOELECTRON; NEURAMINIDASE; NEUROGLIA;

EID: 28244452110     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03444.x     Document Type: Article

References (31)

1. Bartlett G. R. (1959) Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466-468.
2. Cheng I. H., Palop J. J., Esposito L. A., Bien-Ly N., Yan F. and Mucke L. (2004) Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat. Med. 10, 1190-1192.
3. Choo-Smith L. P., Garzon-Rodriguez W., Glabe C. G. and Surewicz W. K. (1997) Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272, 22 987-22 990.
4. Choo-Smith L. P. and Surewicz W. K. (1997) The interaction between Alzheimer Amyloid β (1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402, 95-98.
5. Hayashi H., Kimura N., Yamaguchi H., Hasegawa K., Yokoseki T., Shibata M., Yamamoto N., Michikawa M., Yoshikawa Y., Terao K. et al. (2004) A seed for Alzheimer amyloid in the brain. J. Neurosci. 24, 4894-4902.
6. Hendriks L., van Duijn C. M., Cras P., Cruts M., Van Hul W., van Harskamp F., Warren A., McInnis M. G., Antonarakis S. E., Martin J. J. et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat. Genet. 1, 218-221.
7. Herzig M. C., Winkler D. T., Burgermeister P., Pfeifer M., Kohler E., Schmidt S. D., Banner S., Abramowski D., Sturchler-Pierrat C., Burki K. et al. (2004) Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 1, 954-960.
8. Jones E. M. and Surewics W. K. (2005) Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion proteins. Cell 121, 63-72.
9. Kakio A., Nishimoto S. I., Yanagisawa K., Kozutsumi Y. and Matsuzaki K. (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276, 24 985-24 990.
10. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y. and Matsuzaki K. (2002) Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41, 7385-7390.
11. Kim K. S., Miler D. L., Sapienza V. J., Chen C.-M. J., Bai C., Grundke-Iqbal I. Currie J. R. and Wisniewski H. M. (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 1, 121-130.
12. Levy E., Carman M. D., Fernandez-Madrid I. J., Power M. D., Lieberburg I., van Duinen S. G., Bots G. T., Luyendijk W. and Frangione B. (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126.
13. Matsuzaki K. and Horikiri C. (1999) Interaction of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38, 4137-4142.
14. McLaurin J. and Chakrabartty A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271, 26482-26489.
15. Melchor J. P., McVoy L. and Van Nostrand W. E. (2000) Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein. J. Neurochem. 74, 2209-2212.
16. Molander-Melin M., Blennow K., Bogdanovic N., Dellheden B., Mansson J.-E. and Fredman P. (2005) Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of ganglioside GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J. Neurochem. 92, 171-182.
17. Naiki H. and Gejyo F. (1999) Kinetic analysis of amyloid fibril formation. Meth Enzymol. 309, 305-318.
18. Naiki H. and Nakakuki K. (1996) First-order kinetic model of Alzheimer β-amyloid fibril extension in vitro. Laboratory Invest. 74, 374-382.
19. Nilsberth C., Westlind-Danielsson A., Eckman C. B., Condron M. M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D. B., Younkin S. G. et al. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4, 887-893.
20. Prelli F., Levy E., van Duinen S. G., Bots G. T., Luyendijk W. and Frangione B. (1990) Expression of a normal and variant Alzheimer's β-portein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assay. Biochem. Biophys. Res. Commun. 170, 301-307.
21. Richmond W. (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. & its application to the enzymatic assay of total cholesterol in serum. Clin. Chem. 19, 1350-1356.
22. Rozemuller A. J., Roos R. A., Bots G. T., Kamphorst W., Eikelenboom P. and Van Nostrand W. E. (1993) Distribution of β/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am. J. Pathol. 142, 1449-1457.
23. Selkoe D. J. (1997) Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275, 630-631.
24. Suzuki N., Iwatsubo T., Odaka A., Ishibashi Y., Kitada C. and Ihara Y. (1994) High tissue content of soluble β 1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145, 452-460.
25. Svennerholm L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24, 604-611.
26. Wakabayashi M., Okada T., Kozutsumi Y. and Matsuzaki K. (2005) GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes. Biochem. Biophys. Res. Commun. 328, 1019-1023.
27. Yamamoto N., Hasegawa K., Matsuzaki K., Naiki H. and Yanagisawa K. (2004) Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid β-protein. J. Neurochem. 90, 62-69.
28. Yamamoto N., Hirabayashi Y., Amari M., Yamaguchi H., Romanov G., Van Nostrand W. E. and Yanagisawa K. (2005) Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides. FEBS Lett. 579, 2185-2190.
29. Yanagisawa K. and Ihara Y. (1998) GM1 ganglioside-bound amyloid β-protein in Alzheimer's disease brain. Neurobiol. Aging 19, S65-S67.
30. Yanagisawa K., McLaurin J., Michikawa M., Chakrabartty A. and Ihara Y. (1997) Amyloid β-protein (Aβ) associated with lipid molecules: immunoreactivity distinct from that of soluble Aβ. FEBS Lett. 420, 43-46.
31. Yanagisawa K., Odaka A., Suzuki N. and Ihara Y. (1995) GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066.